Pulmonology · Medical Literature

Severity-Stratified Pulmonary Rehabilitation Modulates Diaphragm Function and Oxidative Stress in Hospitalized AECOPD Patients: A Randomized Controlled Trial.

Abstract

Diaphragmatic dysfunction and oxidative stress are central pathophysiological alterations in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Evidence is lacking regarding early pulmonary rehabilitation protocols stratified by objective disease severity and their physiological effects. This study aimed to evaluate the impact of an individualized, severity-graded exercise rehabilitation program on diaphragmatic function and oxidative stress biomarkers in these patients. In this single-center randomized controlled trial, 132 AECOPD patients were first stratified into three severity grades (I, II, III) based on predefined clinical and physiological criteria, then randomly assigned to either a study group (n=66, receiving severity-graded rehabilitation) or a control group (n=66, receiving conventional rehabilitation).Diaphragmatic function was assessed by bedside ultrasonography measuring excursion (DE), end-inspiratory thickness (DTei), and end-expiratory thickness (DTee). Serum levels of malondialdehyde (MDA), superoxide dismutase (SOD), and total antioxidant capacity (TAOC) were determined. All measurements were taken before and after the intervention. The trial was registered with the Chinese Clinical Trial Registry (ChiCTR2500106687). Compared to the control group, the study group showed significant improvements in all diaphragmatic function parameters (all p<0.001). Furthermore, increases in SOD and TAOC levels were significantly greater in the study group (p=0.005 and p=0.025, respectively). Subgroup analysis revealed that patients with mild disease exhibited the most pronounced improvement in DE (p=0.044), and oxidative stress responses were heterogeneous across severity grades. Partial correlation analysis indicated that improvements in DE were significantly negatively correlated with improvements in all oxidative stress biomarkers only in the study group (r range: -0.314 to -0.331, all p<0.05). Severity-graded exercise rehabilitation effectively improves diaphragmatic function and enhances endogenous antioxidant capacity in hospitalized AECOPD patients. The improvement in diaphragmatic excursion was significantly correlated with favorable changes in oxidative stress biomarkers, suggesting a potential physiological association. These findings support the efficacy of severity-graded rehabilitation but warrant further mechanistic studies.

Clinical relevance

In hospitalized patients with acute exacerbation of COPD (AECOPD), does a severity-stratified, individualized pulmonary rehabilitation program produce greater improvements in diaphragmatic function (assessed by bedside ultrasonography) and oxidative stress biomarkers compared to conventional rehabilitation? __SNAPSHOT__ {"studyDesign":"Single-center randomized controlled trial with pre-specified severity stratification (3 grades) followed by randomization","setting":"Single tertiary-care center, Zunyi, Guizhou, People's Republic of China (The Second Affiliated Hospital of Zunyi Medical University)","sampleSize":"n=132 (intervention/study group: n=66; control group: n=66)","population":"Hospitalized adults with AECOPD stratified prospectively into three clinical/physiological severity grades (Grade I [mild], Grade II [moderate], Grade III [severe]) based on predefined criteria prior to randomization. Specific inclusion/exclusion criteria, age range, baseline spirometry, and comorbidity data not reported in abstract.","intervention":"Severity-graded (individualized) exercise rehabilitation program, with intensity and type of exercise tailored to each patient's assigned severity grade (Grade I, II, or III)","comparator":"Conventional (non-stratified, standard) pulmonary rehabilitation","primaryOutcome":"Diaphragmatic function parameters assessed by bedside ultrasonography: diaphragmatic excursion (DE), end-inspiratory diaphragm thickness (DTei), and end-expiratory diaphragm thickness (DTee). Oxidative stress biomarkers: serum malondialdehyde (MDA), superoxide dismutase (SOD), and total antioxidant capacity (TAOC).","followUp":"Duration of the intervention and follow-up not explicitly reported in the abstract; all measurements taken before and after the in-hospital intervention period","fundingSource":"Not reported"}

Key findings

Compared to conventional rehabilitation, severity-graded rehabilitation produced statistically significant improvements across all three diaphragmatic ultrasound parameters (DE, DTei, DTee; all p<0.001). For oxidative stress biomarkers, SOD and TAOC levels increased significantly more in the intervention group (p=0.005 and p=0.025, respectively); absolute effect sizes and confidence intervals for these between-group differences were not reported. MDA changes were not reported as significant overall in the primary comparison but showed heterogeneity in subgroup analysis: MDA decreased in mild (Grade I; improvement value −1.506) and moderate (Grade II; −0.421) patients, but rose in severe (Grade III) patients (0.853±1.298; p<0.05 vs. mild), indicating a potential pro-oxidant effect of exercise in the most severe subgroup. Subgroup analysis showed the most pronounced improvement in DE among mild-disease patients (p=0.044), and oxidative stress responses were heterogeneous across severity grades. Partial correlation analysis, restricted to the intervention group, revealed that improvement in DE was significantly negatively correlated with improvement in MDA (r=−0.314, p=0.013), SOD (r=−0.331, p=0.009), and TAOC (r=−0.304, p=0.016), suggesting a mechanistic coupling between diaphragmatic functional recovery and antioxidant capacity enhancement specifically in patients receiving severity-graded rehabilitation. NNT could not be calculated from available data. No adverse event data are reported in the abstract.

Practice implications

This RCT establishes that, over the in-hospital period, an individualized severity-stratified pulmonary rehabilitation protocol is associated with statistically significant improvements in bedside ultrasound-measured diaphragmatic function and in endogenous antioxidant markers (SOD, TAOC) compared to standard rehabilitation in AECOPD patients. A notably important subgroup signal is the divergent MDA response in Grade III (severe) patients, where oxidative stress appeared to worsen despite—or in response to—the exercise protocol, indicating that the benefits may not extend uniformly across all severity strata and that very severe patients warrant particular caution and individualized monitoring. The study does NOT establish clinical outcomes of primary importance (e.g., length of hospital stay, readmission rates, mortality, NIV duration, long-term exercise capacity, or quality of life), nor does it demonstrate whether improvements in surrogate biomarkers translate into meaningful patient-centered benefits. Generalizability is restricted to a single Chinese center; findings may not apply across different healthcare systems, patient ethnicities, or COPD phenotypes. The absence of post-discharge follow-up prevents conclusions about durability of benefit. As only the abstract was available for review, this limits assessment of the full statistical reporting, randomization methodology, allocation concealment, blinding procedures, protocol adherence, and missing data handling. __LIMITATIONS__ Single-center design conducted at one institution in Guizhou, China, severely limiting external validity and generalizability,No patient-centered or hard clinical outcomes reported (mortality, readmission, NIV duration, length of stay); all endpoints are physiological surrogates of uncertain clinical magnitude,No post-discharge follow-up; durability of diaphragmatic or biochemical improvements is unknown,Blinding not reported: given the nature of the intervention, blinding of participants and rehabilitation providers is likely not feasible; assessor blinding not described,Absolute between-group differences, confidence intervals, and minimal clinically important differences for ultrasound parameters and biochemical markers are not reported in the abstract, precluding full assessment of clinical importance,The pre-stratification-then-randomization design introduces potential complexity: it is not confirmed whether randomization was performed within each severity stratum (stratified randomization) or globally, risking imbalance,Subgroup analysis by severity grade (Grade I, II, III) appears exploratory and likely underpowered; multiple comparisons increase type I error risk,Adverse event data are absent from the abstract; safety of exercise rehabilitation—particularly in Grade III (severe) patients who showed a rise in MDA—is not quantified,The intervention details (type, intensity, frequency, duration of each graded exercise protocol) are not described in the abstract, limiting reproducibility,Funding source not reported, precluding assessment of potential conflicts of interest,Diaphragm measurements are restricted to the right hemidiaphragm, which may not fully represent bilateral function __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ In hospitalized AECOPD patients, severity-stratified pulmonary rehabilitation produced statistically significant improvements in bedside ultrasound diaphragm parameters and antioxidant markers (SOD, TAOC) compared to conventional rehabilitation, with a mechanistic correlation between diaphragm recovery and oxidative stress attenuation observed exclusively in the intervention group. However, a concerning rise in MDA among the most severe (Grade III) patients warrants caution before broad implementation in this subgroup, and the absence of hard clinical outcomes (mortality, readmission, length of stay) means practice should not change on the basis of this single-center trial alone. Larger, multicenter trials with patient-centered outcomes, post-discharge follow-up, and robust safety reporting are needed before this protocol can be recommended for routine clinical adoption.

Evidence appraisal

Evidence quality rating
5/10
Clinical applicability score
5/10